DSM-IV schizophrenia is a discrete category Like other disorders, DSM-IV defines schizophrenia as a discrete category rather than a quantitative dimension, despite its qualification that “there is no assumption that each category of mental disorder is a completely discrete entity with absolute boundaries dividing it from other mental
disorders or from no mental disorder” (p xxii, DSM-IV). Inhibitors,research,lifescience,medical An implicit implication of this approach is that schizophrenia differs qualitatively from states of health or normalcy. This idea holds that schizophrenia begins with the onset of its symptoms as listed in DSM-IV. Before that time, the disorder cannot be recognized validly; if the criteria for other disorders are also not met, individuals cannot receive any psychiatric diagnoses. To a significant degree, the Inhibitors,research,lifescience,medical “cut point” for making the decision is whether psychotic symptoms arc present
or not. In general, a reliance on discrete Inhibitors,research,lifescience,medical categories raises potential problems for cases that share symptoms of multiple disorders, because they may lead to artificial boundary categories and elevated rates of comorbidity.36 Certainly, dimensional models of psychopathology have conceptual and pragmatic limitations as well.37 For example, although a this website variety of studies have identified underlying dimensions of the diagnostic criteria for schizophrenia, (eg, positive, negative, and disorganized symptoms), both the number and
the content of these dimensions remain unclear.38 These concerns arc significant, but the question remains as to whether a dimensional Inhibitors,research,lifescience,medical model describes the biological nature of schizophrenia more accurately than a categorical one? Is it more valid? Certainly, a dimensional view of schizophrenia is more consistent Inhibitors,research,lifescience,medical (than a categorical one) with polygenic models of inheritance, which is the model that provides the best account of the familial transmission of schizophrenia.23,39 Polygenic models assume that multiple genes combine with one another and with environmental factors to cause schizophrenia. Because Olopatadine multiple genes and environmental risk factors are involved, it is possible for people to have low, moderate, or high “doses” of risk factors that predispose to schizophrenia. People with very high doses are at high risk for schizophrenia, those with moderate doses may have related conditions such as schizotypal personality disorder, negative symptoms, neuropsychological impairment, or other neurobiological manifestations of the predisposition to schizophrenia.40 It is clear that, in this view, a dimensional model describes the range of schizophrenic illness better than does a categorical one.
Related posts:
- Somatic symptoms of depressive disorders in inpatient care and pr
- This kind of assessment would not have been possible by following
- Awareness refers to many higher brain functions There are so man
- If this is true, then medication treatment and psychotherapy may
- In the current sample, Cronbach’s alpha was 0 85 Peritraumatic d